ADC Therapeutics (ADCT) Current Assets (2019 - 2026)
ADC Therapeutics (ADCT) reported Current Assets of $261.71 million for Q2 2026, down 17.9% from $318.76 million a year earlier and down 5.4% from the prior quarter.
ADC Therapeutics (ADCT) Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, ADC Therapeutics posted Current Assets of $306.34 million, up 5.2% from FY2024.
- Current Assets has a five-year compound annual growth rate of -7.4% (FY2020 to FY2025).
- By year, Current Assets came in at $291.25 million in FY2024 (-13.4%), $336.29 million in FY2023 (-22.7%), $434.98 million in FY2022 (-17.2%) and $525.18 million in FY2021 (+16.6%).
- The Q2 2026 figure ranks as the lowest quarterly Current Assets since Q1 2025.
- Year over year, Current Assets gained in two of the last eight quarters, with an average decline of 8.2%.
- The high point for year-over-year Current Assets in five years was Q1 2022 (growth of 24.0%); the low point was Q1 2024 (a decline of 23.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $276.77 million (Q1 2026), $306.34 million (Q4 2025) and $287.15 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 41.36 Bn |
| 10 | ADC Therapeutics | 235.62 Mn | -710.57 Mn | 16.90 Mn | 261.71 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 261.71 Mn |
| Mar 31, 2026 | 276.77 Mn |
| Dec 31, 2025 | 306.34 Mn |
| Sep 30, 2025 | 287.15 Mn |
| Jun 30, 2025 | 318.76 Mn |
| Mar 31, 2025 | 257.99 Mn |
| Dec 31, 2024 | 291.25 Mn |
| Sep 30, 2024 | 333.01 Mn |
| Jun 30, 2024 | 355.36 Mn |
| Mar 31, 2024 | 290.21 Mn |
| Dec 31, 2023 | 336.29 Mn |
| Sep 30, 2023 | 375.60 Mn |
| Jun 30, 2023 | 412.81 Mn |
| Mar 31, 2023 | 380.01 Mn |
| Dec 31, 2022 | 434.98 Mn |
| Sep 30, 2022 | 438.10 Mn |
| Jun 30, 2022 | 424.44 Mn |
| Mar 31, 2022 | 487.71 Mn |
| Dec 31, 2021 | 525.18 Mn |
| Sep 30, 2021 | 568.41 Mn |
ADC Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ADCT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();